These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7560133)

  • 1. A meta-analysis of antidepressant outcome studies that involved children and adolescents.
    Thurber S; Ensign J; Punnett AF; Welter K
    J Clin Psychol; 1995 May; 51(3):340-5. PubMed ID: 7560133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.
    Cox GR; Callahan P; Churchill R; Hunot V; Merry SN; Parker AG; Hetrick SE
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008324. PubMed ID: 23152255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant treatment of depression: a metaanalysis.
    Joffe R; Sokolov S; Streiner D
    Can J Psychiatry; 1996 Dec; 41(10):613-6. PubMed ID: 8978938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract]   [Full Text] [Related]  

  • 5. A meta-analysis of antidepressant outcome under "blinder" conditions.
    Greenberg RP; Bornstein RF; Greenberg MD; Fisher S
    J Consult Clin Psychol; 1992 Oct; 60(5):664-9; discussion 670-7. PubMed ID: 1401382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy of depressed children and adolescents: current issues and potential directions.
    Vasa RA; Carlino AR; Pine DS
    Biol Psychiatry; 2006 Jun; 59(11):1021-8. PubMed ID: 16406250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Placebo effect in the drug therapy of depression].
    Hougaard E; Nielsen T; Zachariae B
    Ugeskr Laeger; 2000 Apr; 162(16):2314-7. PubMed ID: 10827560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressants for depressive disorder in children and adolescents: a database of randomised controlled trials.
    Zhang Y; Zhou X; Pu J; Zhang H; Yang L; Liu L; Zhou C; Yuan S; Jiang X; Xie P
    BMC Psychiatry; 2018 May; 18(1):162. PubMed ID: 29855280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo response and antidepressant clinical trial outcome.
    Khan A; Detke M; Khan SR; Mallinckrodt C
    J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adequacy of reporting randomized, controlled trials in the evaluation of antidepressants.
    Streiner DL; Joffe R
    Can J Psychiatry; 1998 Dec; 43(10):1026-30. PubMed ID: 9868568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depression.
    Amsterdam JD; Dunner DL; Fabre LF; Kiev A; Rush AJ; Goodman LI
    Pharmacopsychiatry; 1989 Jul; 22(4):137-43. PubMed ID: 2668978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy.
    Emslie GJ; Ryan ND; Wagner KD
    J Clin Psychiatry; 2005; 66 Suppl 7():14-20. PubMed ID: 16124837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future.
    Taylor WD; Doraiswamy PM
    Neuropsychopharmacology; 2004 Dec; 29(12):2285-99. PubMed ID: 15340391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy and tolerability of first-generation and newer-generation antidepressant medications for depressive disorders in children and adolescents: study protocol for a systematic review and network meta-analysis.
    Zhou X; Qin B; Whittington C; Cohen D; Liu Y; Del Giovane C; Michael KD; Zhang Y; Xie P
    BMJ Open; 2015 Sep; 5(9):e007768. PubMed ID: 26353868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical approach to antidepressant trials. Blindness protection is necessary, feasible and measurable.
    Even C; Siobud-Dorocant E; Dardennes RM
    Br J Psychiatry; 2000 Jul; 177():47-51. PubMed ID: 10945088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.
    Khan A; Schwartz K; Kolts RL; Ridgway D; Lineberry C
    Biol Psychiatry; 2007 Jul; 62(1):65-71. PubMed ID: 17141744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Appropriateness of antidepressant treatment for mild depression].
    Himmerich H
    MMW Fortschr Med; 2011 Jul; 153(29-31):31-3. PubMed ID: 21830735
    [No Abstract]   [Full Text] [Related]  

  • 18. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.
    Khan A; Brodhead AE; Kolts RL; Brown WA
    J Psychiatr Res; 2005 Mar; 39(2):145-50. PubMed ID: 15589562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between quality of reports of antidepressant randomized controlled trials and treatment estimates: systematic review, meta-analysis, and meta-regression analysis.
    Cipriani A; Malvini L; Furukawa TA; Barbui C
    J Clin Psychopharmacol; 2007 Aug; 27(4):352-6. PubMed ID: 17632218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of antidepressants in the treatment of adolescents and young adults with depression and substance use disorders: a systematic review and meta-analysis.
    Zhou X; Qin B; Del Giovane C; Pan J; Gentile S; Liu Y; Lan X; Yu J; Xie P
    Addiction; 2015 Jan; 110(1):38-48. PubMed ID: 25098732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.